Viewing SEC Facts Units
Company Name:
Akari Therapeutics, Plc
CIK:
1541157
Start Filing Date:
2024-01-01
End Filing Date:
2024-02-29
ACCN:
0000950170-24-060556
Value:
$ 0
Value Error:
$ None
Created By:
Date Filed:
2024-05-15
FY:
2024
Fiscal Period:
Q1
Frame:
CY2024Q1I
Type:
us-gaap
Form:
10-Q
Units:
pure